|
Numbers of cases and age-standardized rates (per million population) with 95% confidence intervals (CIs) by diagnosis, age-group and sex, 1968–2005 |
|||||
| Ages 0–14 |
Ages 15–24 |
||||
| No. |
Rate (95% CI) |
No. |
Rate (95% CI) |
||
|
|
|||||
| CNS tumours |
M |
382 |
31.7 (28.5,35.0) |
224 |
27.3 (23.7,30.9) |
| F |
309 |
27.6 (24.4,30.7) |
165 |
20.2 (17.1,23.3) |
|
| Ependymomas |
M |
51 |
4.6 (3.3,5.8) |
21 |
2.6 (1.6,3.9) |
| F |
21 |
2.0 (1.2,3.1) |
6 |
0.8 (0.3,1.6) |
|
| Astrocytomas |
M |
137 |
11.1 (9.2,12.9) |
76 |
9.3 (7.2,11.4) |
| F |
126 |
11.2 (9.2,13.1) |
54 |
6.6 (4.8,8.4) |
|
| PNET |
M |
78 |
6.7 (5.2,8.2) |
13 |
1.6 (0.8,2.7) |
| F |
45 |
4.2 (3.0,5.4) |
7 |
0.9 (0.4,1.8) |
|
| Other gliomas |
M |
34 |
2.9 (1.9,3.8) |
36 |
4.3 (2.9,5.8) |
| F |
34 |
3.0 (2.0,4.0) |
26 |
3.2 (2.1,4.7) |
|
| Sympathetic nervous system tumours |
M |
102 |
9.8 (7.9,11.7) |
9 |
1.1 (0.5,2.1) |
| F |
95 |
9.7 (7.8,11.7) |
9 |
1.1 (0.5,2.2) |
|
| Retinoblastoma |
M |
38 |
3.9 (2.6,5.1) |
0 |
- |
| F |
50 |
5.4 (3.9,6.8) |
0 |
- |
|
| Renal tumours |
M |
71 |
6.8 (5.2,8.4) |
8 |
0.9 (0.4,1.8) |
| F |
85 |
8.7 (6.9,10.6) |
7 |
0.8 (0.3,1.7) |
|
| Hepatoblastomas |
M |
7 |
0.7 (0.3,1.5) |
0 |
- |
| F |
10 |
1.0 (0.5,1.9) |
2 |
0.2 (0.0,0.8) |
|
| Bone tumours |
M |
65 |
4.7 (3.5,5.8) |
114 |
14.2 (11.6,16.8) |
| F |
56 |
4.3 (3.2,5.5) |
66 |
8.3 (6.3,10.3) |
|
| Osteosarcoma |
M |
34 |
2.4 (1.6,3.3) |
60 |
7.5 (5.6,9.5) |
| F |
37 |
2.8 (1.9,3.8) |
39 |
4.9 (3.4,6.5) |
|
| Ewing's sarcoma |
M |
29 |
2.1 (1.4,3.0) |
36 |
4.5 (3.0,5.9) |
| F |
16 |
1.3 (0.7,2.1) |
16 |
2.0 (1.2,3.3) |
|
| Soft tissue sarcomas |
M |
127 |
11.0 (9.1,13.0) |
89 |
10.9 (8.6,13.2) |
| F |
72 |
6.2 (4.8,7.7) |
94 |
11.7 (9.3,14.0) |
|
| Rhabdomyosarcoma |
M |
75 |
6.8 (5.3,8.4) |
14 |
1.8 (1.0,3.0) |
| F |
39 |
3.6 (2.5,4.7) |
21 |
2.7 (1.6,4.1) |
|
| Other |
M |
52 |
4.2 (3.0,5.4) |
75 |
9.1 (7.1,11.2) |
| F |
33 |
2.6 (1.7,3.5) |
73 |
9.0 (6.9,11.1) |
|
| Germ cell tumours |
M |
55 |
5.2 (3.8,6.6) |
292 |
34.8 (30.8,38.8) |
| F |
60 |
5.5 (4.1,6.9) |
127 |
15.4 (12.7,18.1) |
|
| Gonadal |
M |
32 |
3.2 (2.1,4.3) |
260 |
31.0 (27.2,34.7) |
| F |
18 |
1.4 (0.8,2.2) |
86 |
10.4 (8.2,12.6) |
|
| Non-gonadal |
M |
23 |
2.0 (1.3,3.0) |
32 |
3.8 (2.5,5.2) |
| F |
42 |
4.1 (2.9,5.4) |
41 |
5.0 (3.5,6.6) |
|
| Carcinomas |
M |
39 |
2.9 (2.0,3.9) |
221 |
26.4 (22.9,29.9) |
| F |
54 |
4.5 (3.3,5.7) |
472 |
56.5 (51.4,61.6) |
|
| Thyroid |
M |
9 |
0.7 (0.3,1.3) |
23 |
2.8 (1.7,4.1) |
| F |
9 |
0.7 (0.3,1.4) |
61 |
7.4 (5.6,9.3) |
|
| Melanoma |
M |
7 |
0.5 (0.2,1.1) |
61 |
7.4 (5.5,9.2) |
| F |
16 |
1.4 (0.8,2.3) |
148 |
17.9 (15.0,20.7) |
|
| Skin |
M |
4 |
0.3 (0.1,0.7) |
39 |
4.6 (3.1,6.0) |
| F |
4 |
0.3 (0.1,0.7) |
43 |
5.2 (3.6,6.7) |
|
| Breast |
M |
0 |
- |
1 |
0.1 (0.0,0.7) |
| F |
0 |
- |
42 |
4.9 (3.4,6.4) |
|
| Genital/other reproductive |
M |
0 |
- |
0 |
- |
| F |
1 |
0.1 (0.0,0.6) |
85 |
9.9 (7.8,12.0) |
|
| Lung and bronchial |
M |
1 |
0.1 (0.0,0.4) |
7 |
0.8 (0.3,1.7) |
| F |
2 |
0.1 (0.0,0.5) |
5 |
0.6 (0.2,1.4) |
|
| Colorectal |
M |
0 |
- |
19 |
2.3 (1.4,3.6) |
| F |
2 |
0.1 (0.0,0.5) |
9 |
1.1 (0.5,2.0) |
|
|
|
|||||
| TOTAL |
M |
886 |
76.8 (71.7,81.9) |
957 |
115.7 (108.3,123.0) |
| F |
791 |
73.0 (67.8,78.1) |
942 |
114.3 (107.0,121.6) |
|
Magnanti et al. BMC Cancer 2008 8:89 doi:10.1186/1471-2407-8-89 |
|||||